rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Granules India Ltd.

532482 GRANULES Group (A)

01 Oct,15:53
579.45
21.15 (3.79%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Granules India Ltd.

BUYSELL

146,288 558.30 582.90 - 554.20 724.55 - 319.20 14,045.87
NSE | BSE

Granules India Ltd.

GRANULES

01 Oct,15:59
579.15
20.55 (3.68%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Granules India Ltd.

BUYSELL

7,050,057 558.6 582.15 - 554.40 721.00 - 318.95 40,343.25

News for Granules India Ltd.

Granules India...
Granules India Gets USFDA Nod for Generic Glycopyrrolate Oral Solution
Granules India receives USFDA approval for its generic Glycopyrrolate oral solution, indicated for pediatric patients with drooling due to neurological conditions.
Aug 20, 2024 14:45
India-UAE FTA:...
India-UAE FTA: GTRI Calls for Duty Cuts Withdrawal on Gold, Silver, Diamonds
GTRI recommends India reconsider duty concessions on gold, silver, diamonds, and platinum under the India-UAE FTA, citing concerns over domestic industry impact and potential misuse.
Aug 16, 2024 11:42
Granules India Stock Surges 7% on Strong Earnings
Granules India's shares soared nearly 7% after the company reported a significant increase in net profit for the June quarter. The stock hit a 52-week high on strong earnings.
Jul 31, 2024 12:08
Granules India Profit Surges to Rs 135 cr in Q1 FY24
Granules India's profit after tax soared to Rs 135 crore in the June quarter, driven by strong performance in the formulations segment and North America business.
Jul 30, 2024 16:18
Standard Glass...
Standard Glass Lining IPO: ₹500 Crore Raise, Pharma Focus
Standard Glass Lining Technology, a leading manufacturer of pharma and chemical equipment, files for an IPO seeking ₹500 crore. The IPO includes fresh issuance and an OFS, with proceeds for debt...
Jul 26, 2024 13:08

More News for Granules India Ltd. »

(Rs. Crore)

Financial Results of Granules India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,755.093,931.203,238.443,134.982,309.93
Operating profit801.36838.24644.65861.37494.14
Interest72.0038.6716.3523.7726.86
Gross profit735.14809.50645.81851.32493.73
EPS (Rs)17.9920.6115.5822.3217.47

See more in Research Center »

About Granules India Ltd.

Granules India Limited is an Indian multinational pharmaceutical manufacturing company based in Hyderabad. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. Granules India Limited also operates in the contract research and manufacturing (CRAM) segment. Wikipedia

News for Pharmaceuticals and health care

BP to Continue...
BP to Continue Oil & Gas Ventures with Reliance in India
BP's exclusivity with Reliance Industries has ended but the energy giant will continue to pursue oil and gas ventures with the Mukesh Ambani firm in India.
Oct 02, 2024 12:58
Bombay Stock...
Bombay Stock Exchange Brokers' Forum Appoints New Chairman
The Bombay Stock Exchange Brokers' Forum (BBF) has appointed Anup Gupta as its new chairman, succeeding Kishor Kansagra. Gupta brings extensive financial expertise to the role.
Oct 02, 2024 12:44
Royal Enfield...
Royal Enfield Sales Surge 11% in September
Royal Enfield's wholesales rose 11% to 86,978 units in September, driven by strong domestic demand and new model launches.
Oct 02, 2024 12:34
Jubilant Agro...
Jubilant Agro Sciences Inks Pact for Agro Intermediate Production
Jubilant Agro Sciences has partnered with a leading agrochemical company to produce an agro intermediate, expected to generate over USD 300 million in revenue over the next few years.
Oct 02, 2024 12:16
Real Estate...
Real Estate Investment Soars 45% in Q3 2024: Colliers
Institutional investments in Indian real estate surged to USD 1.15 billion in July-September, driven by strong demand for premium homes and offices. Colliers reports office segment attracting USD...
Oct 02, 2024 11:02

More News »

Top News

BP to Continue...
BP to Continue Oil & Gas Ventures with Reliance in India
BP's exclusivity with Reliance Industries has ended but the energy giant will continue to pursue oil and gas ventures with the Mukesh Ambani firm in India.
Oct 02, 2024 12:58
Bombay Stock...
Bombay Stock Exchange Brokers' Forum Appoints New Chairman
The Bombay Stock Exchange Brokers' Forum (BBF) has appointed Anup Gupta as its new chairman, succeeding Kishor Kansagra. Gupta brings extensive financial expertise to the role.
Oct 02, 2024 12:44
Royal Enfield...
Royal Enfield Sales Surge 11% in September
Royal Enfield's wholesales rose 11% to 86,978 units in September, driven by strong domestic demand and new model launches.
Oct 02, 2024 12:34
Jubilant Agro...
Jubilant Agro Sciences Inks Pact for Agro Intermediate Production
Jubilant Agro Sciences has partnered with a leading agrochemical company to produce an agro intermediate, expected to generate over USD 300 million in revenue over the next few years.
Oct 02, 2024 12:16
Singapore's Role in Bengaluru's Tech Hub Development
Singapore has been a key partner in Bengaluru's tech growth over the past 30 years, fostering innovation and attracting global talent. Learn about their collaboration at the Bengaluru Tech Summit...
Oct 02, 2024 11:51

More Top News »

Report Card

PE Ratios
32.22
EPS (Rs.)
17.99
Sales (Rs. Cr)
851.95
Face Value (Rs.)
1
Net Profit Margin (%)
11.60
Last Bonus
Last Dividend(%)
150
Return on Average Equity
14.07

BSE Announcements from Granules India Ltd. (See all)

announcement Closure of Trading Window - 5 day(s) ago
announcement Announcement under Regulation 30 (LODR)-Press Release / Media Release - 24 Sep 2024

Compare 'Granules India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,926.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,757.90
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,068.35
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,195.75
  • Compare
  • Max Healthcare Institute Ltd.
  • 985.45
  • Compare
  • Alkem Laboratories Ltd.
  • 6,060.90
  • Compare
  • Divi's Laboratories Ltd.
  • 5,446.20
  • Compare

Most Active

  • Change (Rs.)
  •  

Granules India Ltd. performance snapshot

If you had invested Rs.  in Granules India Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Granules India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Granules India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close